FDA Won't OK Pfizer's Under 5 Vax Until 3-Shot Study Is Done
The U.S. Food and Drug Administration will wait until Pfizer and BioNTech complete a clinical trial on the effectiveness of a three-dose COVID-19 vaccine for children between 6 months old and...To view the full article, register now.
Already a subscriber? Click here to view full article